Detailed Information on Publication Record
2022
Dynamics of Whole Virus and Non-Structural Protein 1 (NS1) IgG Response in Mice Immunized with Two Commercial Tick-Borne Encephalitis Vaccines.
SALÁT, Jiří, Petra STRAKOVÁ and Daniel RŮŽEKBasic information
Original name
Dynamics of Whole Virus and Non-Structural Protein 1 (NS1) IgG Response in Mice Immunized with Two Commercial Tick-Borne Encephalitis Vaccines.
Authors
SALÁT, Jiří (203 Czech Republic), Petra STRAKOVÁ (203 Czech Republic) and Daniel RŮŽEK (203 Czech Republic, guarantor, belonging to the institution)
Edition
Vaccines, MDPI, 2022, 2076-393X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10607 Virology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 7.800
RIV identification code
RIV/00216224:14310/22:00126325
Organization unit
Faculty of Science
UT WoS
000833195100001
Keywords in English
tick-borne encephalitis virus; vaccine; non-structural protein 1
Tags
Tags
International impact, Reviewed
Změněno: 22/11/2022 14:53, Mgr. Marie Šípková, DiS.
Abstract
V originále
The presence of a non-structural protein 1 (NS1) in tick-borne encephalitis (TBE) vaccines and the possible induction of an NS1-specific immune response in vaccinated individuals remains a somewhat controversial topic. Previously, we detected the presence of NS1 in the Encepur TBE vaccine by mass spectrometry and found the induction of NS1-specific IgG antibodies in mice vaccinated with the FSME-Immun TBE vaccine. Here, in this follow-up study, we examined the dynamics and extent of the NS1-specific IgG response in mice vaccinated with these two vaccines in more detail and compared it with the IgG response to the whole virus (WV). Mice were vaccinated at two-week intervals with a total of six doses of each vaccine, and levels of IgG antibodies to TBE virus WV and NS1 were measured by ELISA after each dose. Both vaccines elicited a robust anti-WV IgG response after two doses. The Encepur vaccine did not elicit NS1-specific IgG even after all six doses. In contrast, the FSME-Immun vaccine triggered the production of NS1-specific IgG after four doses. The results indicate that FSME-Immun is the only vaccine that elicits an NS1-specific antibody response in mice. However, compared to WV-specific IgG, the NS1-specific response is weaker, and a higher number of doses is required to induce detectable levels of NS1-specific IgG antibodies.